drugset / Trial / NCT00558051

Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer

NCT00558051 ↗

Phase 1 Completed 15 enrolled Pawel Kalinski
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate the administration, safety and immunologic effectiveness of an experimental vaccine for colorectal cancer patients.

Timeline

Start
2008-01
Primary completion
2011-12
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator DC-based vaccine Vaccine 2e+06 cells Intranasal

Indications